세계의 유전자 전달 기술 시장 : 모드별, 용도별, 방법별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Gene Delivery Technologies Market size was valued at USD 3,918 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The method of transferring foreign genetic material-such as DNA or RNA-into host cells is known as gene delivery. For gene delivery to cause gene expression, the host cell's genome must be reached. For gene delivery to be successful, the foreign gene delivery must stay stable inside the host cell and be able to either multiply on its own or integrate into the genome. To accomplish this, foreign DNA must be created as a component of a vector that is intended to infiltrate the target host cell and transfer the transgene to that cell's genome. Recombinant viruses and synthetic vectors (viral and non-viral) are the two types of vectors that are used to transfer genes.

Gene Delivery Technologies Market- Market Dynamics

Growing investment in new technologies to propel market demand

An increase in funding and investment in the industry that supports the research, development, and production of various techniques of gene transfer accelerates the growth in revenue even more. Currently, 70% of gene and cell therapy initiatives use viral vectors, which is driving organic revenue growth for biological delivery technologies. To meet the growing demand, the operational companies are making large investments to increase the capacity at which they can produce viral vectors. The development of new gene delivery systems has been facilitated by the introduction of several revolutionary tools for genetic modifications that have simplified the process by which the scientific community has outlined the intricate nature of disease at the genomic level. Ongoing research to create clinically appropriate vectors, both viral and non-viral, to cure crippling diseases like cancer, Alzheimer's disease, and others with state-of-the-art medicines, additionally increases the market's revenue.

Gene Delivery Technologies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on mode segmentation, the biological segment is expected to dominate the market over the forecast period

Based on the application segmentation, the Gene Therapy held the largest market share in 2023

Based on method segmentation, the Ex vivo segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

Gene Delivery Technologies Market- Segmentation Analysis:

The Global Gene Delivery Technologies Market is segmented based on Mode, Application, Method, and Region.

Based on the mode, the market is categorized into Biological, Chemical and Physical. The biological segment is expected to dominate the market over the forecast period due to Yescarta's and Kymriah's enormous success. Since the first viral vector-based gene therapy products were approved, viral vectors have attracted a lot of attention. End users' approval of viral vectors as the primary delivery modality has been confirmed by the exponential rise in the number of R&D programs based on these vectors.

Based on the application, the market is divided into Infrastructure Gene Therapy, Cell Therapy, Vaccines and Research. The Gene Therapy held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. The revenue generation in this category has been driven by the increasing acceptability of gene-based medicines and the resulting rise in the number of clinical research activities. Global gene therapy product approval rates are rising, which has further fueled the segment's expansion.

Based on the method, the industry is divided into Ex vivo, In vivo and In vitro. The Ex vivo segment is expected to lead the market over the projected period because of its many benefits, including reduced immunogenic reactions and the capacity to evaluate transduction efficiency before re-implantation of cells into the patient. Its excellent transduction efficiency and other qualities make it a popular choice in research environments.

Gene Delivery Technologies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the Gene Delivery Technologies market during the forecast period. In the United States, a significant number of clinical trials are being conducted to evaluate the safety and effectiveness of gene therapy as a potential treatment for HIV/AIDS, cancer, and genetic disorders. Additionally, a sizable portion of the largest businesses involved in the production and marketing of gene delivery technology have their headquarters in the United States. The region's commercial dominance in gene delivery technology can be attributed to several characteristics.

Gene Delivery Technologies Market- Competitive Landscape:

It is projected that the growing interest in gene delivery technologies among both public and private investors would hasten the entry of new firms into the market. To improve their market position, the leading companies are also implementing a number of strategic activities, including licensing, partnerships, and mergers and acquisitions. Notable mergers and acquisitions have taken place in the gene delivery technology business in the last few years.

Recent Developments:

In September 2022, Orchard Therapeutics plc, a leader in global gene therapy, and Kyowa Kirin Co., Ltd., a Japan-based global specialty pharmaceutical company (J-GSP) that develops cutting-edge medical solutions using the newest biotechnology, announced they have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics. Through this acquisition, Kyowa Kirin will be able to optimize the value of Libmeldy(R) and effectively expedite the development of Orchard Therapeutics' next-generation MPS programs in addition to its other early research initiatives, which include frontotemporal dementia (FTD) and a severe genetic form of Crohn's disease. Additionally, the combination of Kyowa Kirin's skills, resources, and infrastructure with Orchard Therapeutics' cutting-edge HSC gene therapy platform technology will facilitate the ongoing development of a number of promising biopharmaceutical candidates with the potential to provide transformative value in medical care, including in therapeutic areas and indications like autoimmune diseases and oncology where Kyowa Kirin has extensive experience.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

QIAGEN

Vectalys

Horizon Discovery Group Co.

OriGene Technologies, Inc.

Oxford Biomedica

SignaGen Laboratories

Thermo Fisher Scientific, Inc.

Takara Bio Inc.

Bio-Rad Laboratories, Inc.

System Biosciences llc

Hoffmann-La Roche AG

Promega Corporation

Sirion-Biotech GmbH

Catalent Inc.

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY MODE- MARKET ANALYSIS, 2019 - 2032

• Biological
• Adenovirus
• Retrovirus
• AAV
• Lentivirus
• Other viruses
• Non-viral
• Chemical
• Physical

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Gene Therapy
• Cell Therapy
• Vaccines
• Research

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

• Ex vivo
• In vivo
• In vitro

GLOBAL GENE DELIVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Gene Delivery Technologies Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Gene Delivery Technologies Market Snippet by Mode
  • 2.1.2.Gene Delivery Technologies Market Snippet by Application
  • 2.1.3.Gene Delivery Technologies Market Snippet by Method
  • 2.1.4.Gene Delivery Technologies Market Snippet by Country
  • 2.1.5.Gene Delivery Technologies Market Snippet by Region
• 2.2.Competitive Insights

3.Gene Delivery Technologies Key Market Trends

• 3.1.Gene Delivery Technologies Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Gene Delivery Technologies Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Gene Delivery Technologies Market Opportunities
• 3.4.Gene Delivery Technologies Market Future Trends

4.Gene Delivery Technologies Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Gene Delivery Technologies Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Gene Delivery Technologies Market Landscape

• 6.1.Gene Delivery Technologies Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Gene Delivery Technologies Market - By Mode

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Mode, 2023 & 2032 (%)
  • 7.1.2.Biological
    • 7.1.2.1.Adenovirus
    • 7.1.2.2.Retrovirus
    • 7.1.2.3.AAV
    • 7.1.2.4.Lentivirus
    • 7.1.2.5.Other viruses
    • 7.1.2.6.Non-viral
  • 7.1.3.Chemical
  • 7.1.4.Physical

8.Gene Delivery Technologies Market - By Application

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2.Gene Therapy
  • 8.1.3.Cell Therapy
  • 8.1.4.Vaccines
  • 8.1.5.Research

9.Gene Delivery Technologies Market - By Method

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Method, 2023 & 2032 (%)
  • 9.1.2.Ex vivo
  • 9.1.3.In vivo
  • 9.1.4.In vitro

10.Gene Delivery Technologies Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.Gene Delivery Technologies Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.Gene Delivery Technologies Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.Gene Delivery Technologies Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.Gene Delivery Technologies Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.Gene Delivery Technologies Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Mode, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Gene Delivery Technologies Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.QIAGEN
  • 11.2.2.Vectalys
  • 11.2.3.Horizon Discovery Group Co.
  • 11.2.4.OriGene Technologies, Inc.
  • 11.2.5.Oxford Biomedica
  • 11.2.6.SignaGen Laboratories
  • 11.2.7.Thermo Fisher Scientific, Inc.
  • 11.2.8.Takara Bio Inc.
  • 11.2.9.Bio-Rad Laboratories, Inc.
  • 11.2.10.System Biosciences llc
  • 11.2.11.Hoffmann-La Roche AG
  • 11.2.12.Promega Corporation
  • 11.2.13.Sirion-Biotech GmbH
  • 11.2.14.Catalent Inc.

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us